Phase I Study of Panobinostat with ICE in Relapsed/Refractory Hodgkin Lymphoma


Phase I Study of Panobinostat with ICE in Relapsed/Refractory Hodgkin Lymphoma
Slides from a presentation at ASH 2013 and transcribed comments from a recent interview with Christopher Flowers, MD, MS (2/24/14)
Oki Y et al. A Phase I study of panobinostat in combination with ICE (ifosfamide, carboplatin and etoposide) in patients with relapsed or refractory classical Hodgkin lymphoma (cHL). Proc ASH 2013;Abstract 252.

Dr Flowers is Associate Professor of Hematology and Medical Oncology at Emory School of Medicine Winship Cancer Institute in Atlanta, Georgia.